Search for content, post, videos

Positive results from Calliditas

Renee Aguiar-Lucander
Calliditas Therapeutics has announced positive topline results from Part A of the global Phase 3 clinical trial NefIgArd, which investigated the effect of Nefecon versus placebo in patients with primary IgA nephropathy (IgAN). The trial met its primary objective of demonstrating a statistically s
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.